(NYSE:MET) by 12.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). Obermeyer Wood Investment Counsel Lllp sold 79,069 shares as the company's stock declined 4.70% while stock markets rallied.
Several other hedge funds have also recently added to or reduced their stakes in the company. During the same quarter last year, the company earned $1.28 EPS. equities research analysts predict that MetLife, Inc. will post 4.43 earnings per share for the current year. Epoch Investment Partners Inc. now owns 10,291,110 shares of the financial services provider's stock worth $534,623,000 after buying an additional 6,954,917 shares during the last quarter. Schroder Investment Management Group lifted its stake in MetLife by 7.8% in the 3rd quarter. BlackRock Inc. now owns 68,475,870 shares of the financial services provider's stock valued at $3,616,895,000 after purchasing an additional 66,475,603 shares during the last quarter. Pacer Advisors Inc. now owns 23,586 shares of the financial services provider's stock valued at $1,225,000 after acquiring an additional 2,208 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of MetLife by 5.5% during the third quarter. Argentus Capital Management LLC now owns 7,922 shares of the financial services provider's stock worth $352,000 after buying an additional 679 shares in the last quarter. Franklin Resources Inc. grew its position in shares of MetLife by 1.6% in the 2nd quarter. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.19. Institutional investors own 76.37% of the company's stock. Morgan Stanley downgraded the shares of MET in report on Wednesday, November 11 to "Equal-Weight" rating. Barclays decreased their target price on MetLife from $67.00 to $60.00 and set an "overweight" rating for the company in a research note on Friday, August 11th. Credit Suisse Group reaffirmed a "neutral" rating and issued a $53.00 price objective (down previously from $64.00) on shares of MetLife in a research report on Monday, August 28th. Sandler O'Neill lowered shares of MetLife from a "buy" rating to a "hold" rating in a research report on Friday, November 10th. Argus Research has "Buy" rating and $55 target. Four research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. RBC Capital Markets has "Buy" rating and $56.0 target.
Padmavati row: Shatrughan Sinha slams Sanjay Leela Bhansali
As per reports now, the makers are apparently waiting for the Gujarat elections (December 9 - 18, 2017) to come to an end. Sinha said that Bhansali should have organised a special screening of Padmavati for Rajput community people.
In other MetLife news, insider Christopher G. Townsend sold 82,731 shares of the stock in a transaction that occurred on Friday, November 3rd. The stock was bought at an average price of $51.13 per share, for a total transaction of $879,691.65. Following the completion of the sale, the insider now directly owns 49,660 shares of the company's stock, valued at approximately $2,711,436. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Christopher G. Townsend sold 55,712 shares of the firm's stock in a transaction on Monday, November 6th. Also included in the list of buyers for the last 3 months Cheryl W Grise who executed a direct buy for 720 shares on October 2, 2017.Director Carlos M Gutierrez bought 720 shares on October 2, 2017, bringing his total number of shares held to 13902. Following the completion of the transaction, the insider now directly owns 25,181 shares in the company, valued at approximately $1,367,076.49. The disclosure for this sale can be found here. (NYSE:MET). North Star Investment Management stated it has 0.1% of its portfolio in MetLife, Inc. (MET) traded down $0.04 on Thursday, hitting $53.00. 3,500,300 shares of the stock were exchanged, compared to its average volume of 5,728,484. Over the course of the a year ago MET has set a 52-week high of $55.91 while the corresponding low set was $44.18. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market capitalization of $55,813.94, a price-to-earnings ratio of 10.20, a price-to-earnings-growth ratio of 1.33 and a beta of 1.49. (NYSE:MET) news was published by Seekingalpha.com which published an article titled: "MetLife: Have You Already MET This 3% Yielder Stock?" on November 27, 2017. They expect $1.12 earnings per share, down 17.04 % or $0.23 from last year's $1.35 per share. MetLife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The company had revenue of $16.10 billion during the quarter, compared to the consensus estimate of $15.47 billion. The company's quarterly revenue was up 1.7% compared to the same quarter past year. Stockholders of record on Monday, November 6th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, November 3rd. This represents a $1.60 annualized dividend and a yield of 2.98%. MetLife's payout ratio is 347.83%. Mutual of America Capital Management LLC raised its stake in shares of Metlife by 6.9% in the third quarter.
- Instagram bosse sur une app de messagerie autonome
- New OnePlus 5T update brings camera UI optimizations, photo quality improvements
- Juan Mata wanted to 'prove himself' to Mourinho at United
- Gladwin hospital named one of the best in the nation
- FDA releases long-awaited clinical decision support guidance, clarifies oversight of mobile apps
- 2 killed, 2 injured in knife attack in Tokyo
- S&P 500 breaks four-day slump, end slightly higher
- Malcom forfait pour la réception de Strasbourg — Bordeaux
- Edward Jones Upgrades Suncor Energy (SU) to "Buy"
- Bernie Sanders: Trump Should 'Also Think About Resigning' Over Sexual Misconduct Allegations